Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease
References (17)
- et al.
Predictability of the postoperative course of Crohn's Disease
Gastroenterology
(1990) - et al.
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease
Gastroenterology
(1992) - et al.
Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives
- et al.
Risk factors for first operation in Crohn's disease
Am J Gastroenterol
(1989) - et al.
Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms
Gut
(1992) Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease
Aliment Pharmacol Ther
(1990)- et al.
Prevention of Crohn's disease recurrences after intestinal resection with Eudragit-L-coated 5-aminosalicylic acid: preliminary results of a 1-year double-blind placebo controlled study
Gastroenterology
(1991) - et al.
Placebo-controlled trial of Claversal in the prevention of early endoscopic relapse after “curative” resection for Crohn's disease
Gastroenterology
(1992)
There are more references available in the full text version of this article.
Cited by (196)
Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review
2018, Clinical Gastroenterology and HepatologyCitation Excerpt :In total, 11,408 records were identified (Figure 1). The final analysis incorporated 116 studies, of which 81 reported on induction,14–92 44 on maintenance,14,22,24,25,47,58,67,72–76,83,85,88,93–120 and 7 on postoperative prevention trials (Table 1 and Supplementary Table 3).14,121–126 There were 35.5% of participants (9677 of 27,263) randomized to placebo.
Surgical Considerations in the Treatment of Small Bowel Crohn’s Disease
2017, Journal of Gastrointestinal Surgery
Copyright © 1995 Published by Elsevier Inc.